85 / 110
235
Tabaquismo en pacientes con diagnóstico psiquiátrico
León J. Nicotine dependence and symptoms in schi-
zophrenia: naturalistic study of complex interactions.
The British journal of psychiatry: the journal of mental
science 2005; 186: 215-21.
15.- Ziedonis DM, Amass L, Steinberg M,
Woody G, Krejci J, Annon JJ, et al. Predictors
of outcome for short-term medically supervised opioid
withdrawal during a randomized, multicenter trial of
buprenorphine-naloxone and clonidine in the NIDA
clinical trials network drug and alcohol dependence.
Drug and alcohol dependence 2009; 99: 28-36.
16.- Lawn SJ. Systemic barriers to quitting smoking
among institutionalised public mental health service
populations: a comparison of two Australian sites. The
International journal of social psychiatry 2004; 50: 204-
15.
17.- Nash MJ, Romanos MT. An exploration of men-
tal health nursing students’ experiences and attitudes
towards using cigarettes to change client’s behaviour.
Journal of psychiatric and mental health nursing 2010;
17: 683-91.
18.- Lawn S. Integrating service user participation in men-
tal health care: what will it take? International journal of
integrated care 2015; 15: e004.
19.- Dwyer T, Bradshaw J, Happell B. Compari-
son of mental health nurses’ attitudes towards smoking
and smoking behaviour. International journal of mental
health nursing 2009; 18: 424-33.
20.- Peckham E, Bradshaw TJ, Brabyn S,
Knowles S, Gilbody S. Exploring why people
with SMI smoke and why they may want to quit: base-
line data from the SCIMITAR RCT. Journal of psychia-
tric and mental health nursing. 2015.
21.- Ratschen E, Britton J, Doody GA, Leo-
nardi-Bee J, McNeill A. Tobacco dependence,
treatment and smoke-free policies: a survey of mental
health professionals’ knowledge and attitudes. General
hospital psychiatry 2009; 31: 576-82.
22.- Health AoSa. The Stolen Years 2016. Available from:
http://www.ash.org.uk/files/documents/ASH_1018.pdf.23.- Banham L, Gilbody S. Smoking cessation in severe
mental illness: what works? Addiction. 2010;105:1176-
89.
24.- Tsoi DT, Porwal M, Webster AC. Interventions
for smoking cessation and reduction in individuals with
schizophrenia. The Cochrane database of systematic
reviews 2013; 2: CD007253.
25.- Anthenelli RM, Benowitz NL, West R,
St Aubin L, McRae T, Lawrence D, et al.
Neuropsychiatric safety and efficacy of varenicline, bu-
propion, and nicotine patch in smokers with and without
psychiatric disorders (EAGLES): a double-blind, ran-
domised, placebo-controlled clinical trial. Lancet 2016;
387(10037): 2507-20.
Correspondencia a:
Dr. Juan Trebilcock G.
Email: jjtrebilcoc
k@gmail.com
Rev Chil Enferm Respir 2017; 33: 232-235